drugset / Trial / NCT07263594
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This study, the first clinical trial, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of DB-1324.
Timeline
- Start
- 2026-01-20
- Primary completion
- 2028-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DB-1324 | Unknown | — | Intravenous |